Translate
Novaccess Global Inc.
About
0.00USD+0.00 +0.00%
Closed • Updated at 05:23 GMT+00:00Market Cap$6.2K
Volume250
Beta69.50
RSI44.20
Novaccess Global Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 21 2024
NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer Fighting Vaccine Platform
May 7 2024
NovAccess Global Advisory on Annual Meeting of Shareholders
Apr 30 2024
NovAccess Global Announces New License to Advance its Immunotherapy Platform
Mar 1 2024
NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders
Jan 2 2024
NovAccess Global Announces $10.7 Million Financing
Recent Videos
NovAccess Global - $XSNX - Ep:005 - Nano Cap Podcast
Jan 19, 2026
Promising Breakthrough in Glioblastoma Treatment: NovAccess Global's Revolutionary Technology
Jul 20, 2023
Promising Breakthrough in Glioblastoma Treatment: NovAccess Global's Revolutionary Technology
Jul 19, 2023
WODC23 Highlights | Dwain Irvin, PhD, MPH - NovAccess Global's Groundbreaking TLR-AD1 Immunotherapy
Jun 21, 2023
Community Chat
Ask AI
Try asking